학술논문
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
Document Type
Article
Author
Pitisuttithum, Punnee; Luvira, Viravarn; Lawpoolsri, Saranath; Muangnoicharoen, Sant; Kamolratanakul, Supitcha; Sivakorn, Chaisith; Narakorn, Piengthong; Surichan, Somchaiya; Prangpratanporn, Sumalee; Puksuriwong, Suttida; Lamola, Steven; Mercer, Laina D.; Raghunandan, Rama; Sun, Weina; Liu, Yonghong; Carreño, Juan Manuel; Scharf, Rami; Phumratanaprapin, Weerapong; Amanat, Fatima; Gagnon, Luc; Hsieh, Ching-Lin; Kaweepornpoj, Ruangchai; Khan, Sarwat; Lal, Manjari; McCroskery, Stephen; McLellan, Jason; Mena, Ignacio; Meseck, Marcia; Phonrat, Benjaluck; Sabmee, Yupa; Singchareon, Ratsamikorn; Slamanig, Stefan; Suthepakul, Nava; Tcheou, Johnstone; Thantamnu, Narumon; Theerasurakarn, Sompone; Tran, Steven; Vilasmongkolchai, Thanakrit; White, Jessica A; Bhardwaj, Nina; Garcia-Sastre, Adolfo; Palese, Peter; Krammer, Florian; Poopipatpol, Kittisak; Wirachwong, Ponthip; Hjorth, Richard; Innis, Bruce L
Source
In eClinicalMedicine March 2022 45
Subject
Language
ISSN
2589-5370